Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.01 0.12 (1.74%) Market Cap: 931.14 Mil Enterprise Value: 916.20 Mil PE Ratio: 0 PB Ratio: 2.26 GF Score: 82/100

Maravai LifeSciences Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 16, 2023 / 09:00PM GMT
Release Date Price: $10.4 (+0.19%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Welcome to our next fireside chat here with Maravai LifeSciences, excited to have Trey Martin, CEO; and Kevin Herde, CFO with us today. I'm John Sourbeer, one of the UBS life sciences analyst. Joining me today is Liza Garcia, my co-coverage.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So Trey, I think this might be the first fireside chat you've done since taking over officially as the CEO role. Congrats there. Maybe just high level here, while the first time in the fireside chat. Can you provide some color on your vision for Maravai's portfolio of assets. Do you see any change in strategy? How are you viewing your strategy here now taking over the CEO role officially?

William E. Martin
Maravai LifeSciences Holdings, Inc. - CEO

Yes. So I would say part of the situational assessment is what do you come into. And Maravai has certainly had one of the more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot